Physician perceptions of the use of medications for attention deficit hyperactivity disorder
- PMID: 14613439
- PMCID: PMC10437242
- DOI: 10.18553/jmcp.2003.9.5.416
Physician perceptions of the use of medications for attention deficit hyperactivity disorder
Abstract
Background: Attention deficit hyperactivity disorder (ADHD) is a prevalent mental health condition, occurring in 3% to 5% of school-aged children. Although stimulant medications are a recommended treatment for this disorder, physicians. views of these medications have not been systematically evaluated.
Objective: This study examined physician-prescriber perceptions of using medications to treat ADHD symptoms in children or adolescents.
Methods: A survey was developed with 4 physicians expert in treating ADHD in children. The survey was pilot-tested with a sample of 10 practicing physicians. A sample of 1,000 physicians, with a history of prescribing stimulant medications to children or adolescents, was randomly selected and mailed a 30-item survey. Items were rated on a 7-point response scale (strongly agree, agree, slightly agree, undecided, slightly disagree, disagree, strongly disagree).
Results: A total of 365 physicians responded to the survey, for a 37% response rate. More than 92% of respondents strongly agreed or agreed that ADHD symptoms cause problems in pediatric patients and stimulants are effective in treating ADHD. The stimulant drug side effects of decreased appetite or weight loss, sleep disruption, and exacerbation of anxiety were a concern (strongly agree or agree response) for 32%, 50%, and 22% of physicians, respectively. Diversion of ADHD medication was a concern for 19% of respondents. Physicians reported that controlled medications for children or adolescents with ADHD are a burden for themselves (32% strongly agreed or agreed), for their staff (37% strongly agreed or agreed), and for parents (40% strongly agreed or agreed). Approximately 38% of physicians responded that they would prefer prescribing a nonstimulant medication with a U.S. Food and Drug Administration indication for treating children or adolescents instead of a stimulant medication, and 58% would prefer prescribing a noncontrolled medication that does not have evidence of abuse potential versus one that is controlled and has evidence of abuse potential.
Conclusion: Although physicians overwhelmingly perceive stimulant medications as being effective for treating ADHD symptoms in children or adolescents, many would prefer a nonstimulant medication. While many physicians consider the side effects of the stimulants easily managed, others are concerned about prescribing stimulants because of their side effects, risk of diversion, and administrative burden. The majority of physicians would prefer to prescribe a noncontrolled medication without abuse potential instead of a controlled medication to treat children or adolescents with ADHD.
Similar articles
-
Physician practices to prevent ADHD stimulant diversion and misuse.J Subst Abuse Treat. 2017 Mar;74:26-34. doi: 10.1016/j.jsat.2016.12.003. Epub 2016 Dec 21. J Subst Abuse Treat. 2017. PMID: 28132697
-
Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association.JAMA. 1998 Apr 8;279(14):1100-7. doi: 10.1001/jama.279.14.1100. JAMA. 1998. PMID: 9546570 Review.
-
The Effects of Long-Acting Stimulant and Nonstimulant Medications in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Meta-Analysis of Randomized Controlled Trials.J Child Adolesc Psychopharmacol. 2018 Oct;28(8):494-507. doi: 10.1089/cap.2017.0151. Epub 2018 Jun 13. J Child Adolesc Psychopharmacol. 2018. PMID: 29897263 Review.
-
Physician Training and Qualification to Educate Patients on Attention-Deficit/Hyperactivity Disorder Stimulant Diversion and Misuse.J Child Adolesc Psychopharmacol. 2018 Oct;28(8):554-561. doi: 10.1089/cap.2017.0066. Epub 2018 Aug 20. J Child Adolesc Psychopharmacol. 2018. PMID: 30124331
-
Five-fold increase in national prevalence rates of attention-deficit/hyperactivity disorder medications for children and adolescents with autism spectrum disorder, attention-deficit/hyperactivity disorder, and other psychiatric disorders: a Danish register-based study.J Child Adolesc Psychopharmacol. 2013 Sep;23(7):432-9. doi: 10.1089/cap.2012.0111. Epub 2013 Sep 9. J Child Adolesc Psychopharmacol. 2013. PMID: 24015896 Free PMC article.
Cited by
-
Variation in attitudes toward diagnosis and medication of ADHD: a survey among clinicians in the Norwegian child and adolescent mental health services.Eur Child Adolesc Psychiatry. 2023 Dec;32(12):2557-2567. doi: 10.1007/s00787-022-02110-7. Epub 2022 Nov 19. Eur Child Adolesc Psychiatry. 2023. PMID: 36401019 Free PMC article.
-
Willingness to use ADHD treatments: a mixed methods study of perceptions by adolescents, parents, health professionals and teachers.Soc Sci Med. 2012 Jan;74(1):92-100. doi: 10.1016/j.socscimed.2011.10.009. Epub 2011 Nov 17. Soc Sci Med. 2012. PMID: 22133584 Free PMC article.
-
Preferences related to attention-deficit/hyperactivity disorder and its treatment.Patient Prefer Adherence. 2011 Jan 17;5:33-43. doi: 10.2147/PPA.S6389. Patient Prefer Adherence. 2011. PMID: 21311700 Free PMC article.
-
Misuse of prescribed stimulant medication for ADHD and associated patterns of substance use: preliminary analysis among college students.J Pharm Pract. 2011 Dec;24(6):551-60. doi: 10.1177/0897190011426558. Epub 2011 Nov 17. J Pharm Pract. 2011. PMID: 22095577 Free PMC article.
-
Misuse and diversion of stimulant medications prescribed for the treatment of ADHD: a systematic review.Front Psychiatry. 2025 Jun 30;16:1612785. doi: 10.3389/fpsyt.2025.1612785. eCollection 2025. Front Psychiatry. 2025. PMID: 40698051 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical